TRAF2 and breast carcinoma: Our present in vivo, ex vivo and in vitro investigation showed that TRAF2 overexpression in parental and osteotropic sub-clones of MDA-231 human breast cancer cells increased tumour cell growth and motility, whereas its knockdown is inhibitory.